Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with higher response to fibrogenic signals and might be more pro-inflammatory

A subset of severe COVID19 patients develop pulmonary fibrosis, but the pathophysiology of this complication is still unclear. We previously described the possibility to isolate lung mesenchymal cells (LMC) by culturing broncho-alveolar lavage (BAL) cells from patients with pulmonary fibrosis or chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozzini, Sara, Della Zoppa, Matteo, Bagnera, Cecilia, Bozza, Eleonora, Croce, Stefania, Valsecchi, Chiara, Belliato, Mirko, Pandolfi, Laura, Morbini, Patrizia, Comoli, Patrizia, Avanzini, Maria Antonietta, Meloni, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063673/
https://www.ncbi.nlm.nih.gov/pubmed/37004325
http://dx.doi.org/10.1016/j.biopha.2023.114640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063673/
https://www.ncbi.nlm.nih.gov/pubmed/37004325
http://dx.doi.org/10.1016/j.biopha.2023.114640

Ejemplares similares